Jo Neil on the benefits of Using Psychedelic Drugs as Medicine
Aug 3, 2023 ·
32m 47s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Professor Jo Neal is Professor of Psychopharmacology at the University of Manchester. She is Chair of the Medical Psychedelics Working Group at Drug Science, a Trustee for Heroic Hearts UK,...
show more
Professor Jo Neal is Professor of Psychopharmacology at the University of Manchester. She is Chair of the Medical Psychedelics Working Group at Drug Science, a Trustee for Heroic Hearts UK, scientific advisor for the Conservative Drug Policy Reform Group, Beckley Psytech, Albert Labs, and Octarine Bio. Jo is an advisory board member of the International Therapeutic Psilocybin Rescheduling Initiative. She is co-founder of b-neuro, a University based Contract Research Organisation developing new treatments for mental illness through animal models and past President of the British Association for Psychopharmacology (President 2016-2018). She served on the Research Excellence Framework panel for Unit of Assessment 3 (Allied Health Professions, Dentistry, Nursing and Pharmacy) in 2014. Jo is working with Policy at Manchester and Drug Science to educate the public about the urgent need for drug law reform and suspension of Schedule 1 restrictions to enable research into the medicinal properties of currently illegal drugs. Drugreporter produced a new documentary on the struggle to liberate psychedelic medicine in Scotland. In the film, people with lived experience provide testimony on the healing powers of psychedelic drugs. We decided to publish the uncut interviews as well, for a more in-depth analysis of the situation of psychedelics in Scotland. To watch the film, Psychedelics in Scotland, click here: https://youtu.be/7JMpPTvTXo0
show less
Information
| Author | Rights Reporter Foundation |
| Organization | Rights Reporter Foundation |
| Website | drogriporter.hu |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
